Wellington Management Group LLP grew its stake in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 16.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 883,221 shares of the company's stock after purchasing an additional 122,846 shares during the period. Wellington Management Group LLP owned approximately 3.65% of OrthoPediatrics worth $23,944,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also modified their holdings of the stock. Quarry LP bought a new position in OrthoPediatrics in the 3rd quarter worth approximately $25,000. International Assets Investment Management LLC lifted its stake in shares of OrthoPediatrics by 2,610.8% during the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company's stock valued at $27,000 after acquiring an additional 966 shares during the period. Quest Partners LLC bought a new position in OrthoPediatrics in the second quarter valued at about $34,000. BNP Paribas Financial Markets lifted its position in OrthoPediatrics by 125.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company's stock valued at $94,000 after purchasing an additional 1,929 shares during the period. Finally, SG Americas Securities LLC bought a new stake in shares of OrthoPediatrics during the second quarter worth approximately $110,000. 69.05% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research firms have weighed in on KIDS. JMP Securities reiterated a "market outperform" rating and issued a $50.00 target price on shares of OrthoPediatrics in a report on Friday, September 13th. Truist Financial reduced their target price on shares of OrthoPediatrics from $34.00 to $28.00 and set a "hold" rating for the company in a report on Monday, October 14th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $42.00 price target on shares of OrthoPediatrics in a research report on Friday, November 8th.
Get Our Latest Analysis on OrthoPediatrics
OrthoPediatrics Stock Performance
OrthoPediatrics stock traded up $0.20 during trading hours on Friday, hitting $22.12. The company had a trading volume of 325,911 shares, compared to its average volume of 172,028. OrthoPediatrics Corp. has a one year low of $21.02 and a one year high of $36.23. The firm has a market cap of $535.75 million, a PE ratio of -17.98 and a beta of 1.14. The firm has a 50-day moving average of $25.47 and a 200 day moving average of $28.51. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68.
OrthoPediatrics Profile
(
Free Report)
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Featured Articles
Before you consider OrthoPediatrics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OrthoPediatrics wasn't on the list.
While OrthoPediatrics currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
